Ozempic / Victoza
Submitted by Anonymous (not verified) on 1 December 2023 - 10:49
Ozempic / Victoza
Submitted by Anonymous (not verified) on 1 December 2023 - 10:45
Update on human variations web-based electronic application form implementation on product lifecycle management portal, Online, from 6 November 2023, 13:30 (CET) to 6 November 2023, 15:00 (CET)
Submitted by Anonymous (not verified) on 1 December 2023 - 10:32
Update on human variations web-based electronic application form implementation on product lifecycle management portal, Online, from 6 November 2023, 13:30 (CET) to 6 November 2023, 15:00 (CET)
Update on human variations web-based electronic application form implementation on product lifecycle management portal, Online, 13:30 - 15:00 Amsterdam time (CEST), from 06/11/2023 to 06/11/2023
Submitted by Anonymous (not verified) on 1 December 2023 - 10:26
Update on human variations web-based electronic application form implementation on product lifecycle management portal, Online, 13:30 - 15:00 Amsterdam time (CEST), from 06/11/2023 to 06/11/2023
Herbal medicinal product: Maydis stigmaArray, D: Draft under discussion
Submitted by Anonymous (not verified) on 1 December 2023 - 10:25
Herbal medicinal product: Maydis stigmaArray, D: Draft under discussion
Submitted by Anonymous (not verified) on 1 December 2023 - 10:15
Second European Medicines Agency (EMA) and EUCOPE bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 29 November 2023
Submitted by Anonymous (not verified) on 1 December 2023 - 10:13
Second European Medicines Agency (EMA) and EUCOPE bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 29 November 2023
Human medicines European public assessment report (EPAR): Plavix, clopidogrel, Stroke;Peripheral Vascular Diseases;Atrial Fibrillation;Myocardial Infarction;Acute Coronary Syndrome, Date of authorisation: 15/07/1998, Revision: 50, Status: Authorised
Submitted by Anonymous (not verified) on 1 December 2023 - 10:08
Human medicines European public assessment report (EPAR): Plavix, clopidogrel, Stroke;Peripheral Vascular Diseases;Atrial Fibrillation;Myocardial Infarction;Acute Coronary Syndrome, Date of authorisation: 15/07/1998, Revision: 50, Status: Authorised
Second European Medicines Agency (EMA) and EUCOPE bilateral meeting, European Medicines Agency , from 29/11/2023 to 29/11/2023
Submitted by Anonymous (not verified) on 1 December 2023 - 10:01
Second European Medicines Agency (EMA) and EUCOPE bilateral meeting, European Medicines Agency , from 29/11/2023 to 29/11/2023
Human medicines European public assessment report (EPAR): Cialis, tadalafil, Erectile Dysfunction, Date of authorisation: 12/11/2002, Revision: 32, Status: Authorised
Submitted by Anonymous (not verified) on 1 December 2023 - 10:00
Human medicines European public assessment report (EPAR): Cialis, tadalafil, Erectile Dysfunction, Date of authorisation: 12/11/2002, Revision: 32, Status: Authorised